PRESS RELEASE

XIFIN Named to Inc. 5000 List of Fastest-Growing Private Companies in America for Sixth Consecutive Year

San Diego, Calif. – August 28, 2012 -- XIFIN, Inc., the company revolutionizing revenue cycle management for diagnostic service providers, today announced it has been named to the 2012 Inc. 5000 list of fastest-growing private companies for the sixth consecutive year. The company's three year growth rate from 2008 to 2011 earned it an exclusive ranking among the most important segment of the economy – America’s independent entrepreneurs. The company ranked No. 149 in Top Software Companies, and No. 39 in Top Companies in the San Diego Metro Area.

With this accomplishment, XIFIN joins an exceptional group of companies that have appeared on the list multiple times, many of which have grown to become national icons.

"Receiving this award six years in a row is a tremendous honor that recognizes the strong demand for our next generation, cloud-based technology platform," said Lâle White, CEO of XIFIN. "I would like to thank the entire XIFIN team and our customer partners for their ongoing commitment and contribution to our success."

XIFIN processes more than 100 million claims per year across a wide variety of healthcare segments including radiology, clinical, hospital outreach, anatomic pathology, molecular diagnostics, toxicology and more. Customers see significant improvements in profitability by collecting 8 percent additional cash on average in the first 12 months, and have realized cumulative gains of $1 billion in net cash collection, adjusted for growth. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region and other criteria can be found on www.inc.com/5000.


About XIFIN

XIFIN is an innovative software and services company dedicated to optimizing the economics of healthcare. The company's cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making. To learn more, visit www.XIFIN.com, or follow XIFIN on Twitter at www.twitter.com/#!/xifin.


XIFIN

Media Relations

To speak with XIFIN directly, contact Fran DuCharme at 858.436.2939 or complete the form below for assistance.

To speak with our PR firm, contact Julie Sculley at 617.986.5730.